Today's technical alert provides information on the Therapeutic Goods Advertsising Annual Report 2021-22; and the TGA update to the approach to overseas manufacturers during the OCVID-19 Pandemic: GMP Clearance MRA pathway.

Therapeutic Goods Advertising Annual Report 2021-22

The annual outcomes of the TGA’s 2021-22 advertising compliance and enforcement activities have been published in the Therapeutic Goods Advertising Annual Report 2021-22 on the TGA website. This tech alert provides contextually relevant information for members, including in relation to listed and complementary medicines. 

TGA update to the GMP approach to overseas manufacturers during the COVID-19 Pandemic: GMP Clearance Pathway 

The TGA have provided an update their GMP approach to overseas manufacturers during the COVID-19 Pandemic, which outlines additional options for Australian Sponsors to maintain their GMP Clearance validity and provides additional application guidance.

Please read today’s full tech alert for more information.